{
    "clinical_study": {
        "@rank": "114392", 
        "acronym": "TRAIN-2", 
        "arm_group": [
            {
                "arm_group_label": "FEC-T +Pertuzumab", 
                "arm_group_type": "Active Comparator", 
                "description": "Fluorouracil; 500 mg/m2; day 1 Epirubicine; 90 mg/m2; day 1 Cyclophosphamide; 500 mg/m2; day 1 Trastuzumab; 6 mg/kg (loading dose 8 mg/kg) Pertuzumab; 420 mg (loading dose 840 mg); day 1 Cycle is repeated every 21 days"
            }, 
            {
                "arm_group_label": "PTC+Pertuzumab", 
                "arm_group_type": "Active Comparator", 
                "description": "Paclitaxel; 80 mg/m2; day 1,8 Trastuzumab; 6 mg/kg (loading dose 8 mg/kg); day 1 Carboplatin; AUC=6; day 1 Pertuzumab; 420 mg (loading dose 840 mg); day 1 Cycle repeated every 21 days"
            }
        ], 
        "brief_summary": {
            "textblock": "This study compares two schedules of upfront chemotherapy in HER positive breast cancer."
        }, 
        "brief_title": "Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer, TRAIN-2", 
        "completion_date": {
            "#text": "December 2019", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Breast Cancer", 
            "HER2 Positive"
        ], 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "Upfront trastuzumab treatment is beneficial to patients with HER2 positive breast cancer.\n      The potential synergistic cardiotoxicity of trastuzumab and anthracyclines has led to the\n      development of non-anthracycline containing regimens, which have shown high pathologic\n      complete response rates. Anthracyclines remain very active in HER2 positive breast cancer,\n      however, and increasing evidence now supports safe combination of trastuzumab and\n      epirubicin. Therefore, the addition of epirubicin to a non-anthracycline containing regimen\n      may further improve outcome for patients with HER2 positive breast cancer.\n\n      Several reports confirmed benefit of dual HER2 blockade by adding pertuzumab to a\n      trastuzumab containing neoadjuvant regimen. The results of the combined treatment in the\n      Neosphere study, however, are similar to what we found in a phase II trial using a weekly\n      paclitaxel, trastuzumab, carboplatin combination with pCR rates of approximately 44%. Adding\n      pertuzumab to this regimen is likely to also increase the high pCR rate and to add\n      substantial benefit to patients."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Histologically confirmed infiltrating breast cancer\n\n          -  Stage II or stage III disease. Nodal status must be examined by ultrasound, fine\n             needle aspiration, sentinel node biopsy, or FDG-PET scan.\n\n          -  Overexpression and/or amplification of HER2 in an invasive component of the core\n             biopsy, according to one of the following definitions:\n\n             \u2022>30% of invasive tumor cells showing strong complete circumferential membrane\n             staining (score 3+)\n\n             \u2022HER2 gene amplification defined as >6 HER2 gene copies per nucleus by in situ\n             hybridization.\n\n          -  Age \u226518\n\n          -  Eastern Cooperative Oncology Group performance status \u22641\n\n          -  Adequate bone marrow function (ANC >1.5 x 109/l, platelets >100 x 109/l)\n\n          -  Adequate hepatic function (ALAT, ASAT and bilirubin <2.5 times upper limit of normal)\n\n          -  Adequate renal function (creatinine clearance >50 ml/min)\n\n          -  LVEF \u226550% measured by echocardiography or MUGA\n\n          -  Absence of any psychological, familial, sociological, or geographical condition\n             potentially hampering compliance with the study protocol and follow-up schedule\n\n          -  Absence of any medical condition that would place the patient at unusual risk.\n\n          -  Signed written informed consent\n\n        Exclusion Criteria:\n\n          -  previous radiation therapy or chemotherapy\n\n          -  other malignancy except carcinoma in situ, unless the other malignancy was treated \u22655\n             years ago with curative intent without the use of chemotherapy or radiation therapy.\n\n          -  current pregnancy or breastfeeding. Women of childbearing potential must use adequate\n             contraceptive protection\n\n          -  evidence of distant metastases. Evaluation of the presence of distant metastases may\n             include chest X-ray, liver ultrasound, isotope bone-scan, CT-scan of chest and\n             abdomen and/or FDG-PET scan, according to local procedures.\n\n          -  evidence of bilateral infiltrating breast cancer. Evaluation of the presence of\n             bilateral infiltrating breast cancer may include mammography, breast ultrasound\n             and/or MRI breast.\n\n          -  concurrent anti-cancer treatment or another investigational drug."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "437", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01996267", 
            "org_study_id": "M13TRT"
        }, 
        "intervention": [
            {
                "arm_group_label": "PTC+Pertuzumab", 
                "intervention_name": "PTC+Pertuzumab", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Paclitaxel; 80 mg/m2; day 1,8", 
                    "Trastuzumab; 6 mg/kg (loading dose 8 mg/kg); day 1", 
                    "Carboplatin; AUC=6; day 1", 
                    "Pertuzumab; 420 mg (loading dose 840 mg); day 1", 
                    "Cycle repeated every 21 days"
                ]
            }, 
            {
                "arm_group_label": "FEC-T +Pertuzumab", 
                "intervention_name": "FEC-T+Pertuzumab", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Fluorouracil; 500 mg/m2; day 1", 
                    "Epirubicine; 90 mg/m2; day 1", 
                    "Cyclophosphamide 500 mg/m2; day 1", 
                    "Trastuzumab; 6 mg/kg (loading dose 8 mg/kg)", 
                    "Pertuzumab; 420 mg (loading dose 840 mg); day 1", 
                    "Cycle is repeated every 21 days"
                ]
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Cyclophosphamide", 
                "Fluorouracil", 
                "Trastuzumab", 
                "Carboplatin", 
                "Paclitaxel"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "neoadjuvant", 
            "breast cancer", 
            "HER2 positive"
        ], 
        "lastchanged_date": "May 22, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "S Vrijaldenhoven, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Alkmaar", 
                        "country": "Netherlands", 
                        "zip": "1815 JD"
                    }, 
                    "name": "MCA"
                }, 
                "investigator": {
                    "last_name": "S Vrijaldenhoven, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "i.oving@zgt.nl", 
                    "last_name": "I M Oving, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Almelo", 
                        "country": "Netherlands", 
                        "zip": "7609 PP"
                    }, 
                    "name": "ZGT"
                }, 
                "investigator": {
                    "last_name": "I M Oving, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "g.sonke@nki.nl", 
                    "last_name": "Gabe S Sonke, MD", 
                    "phone": "+3120512", 
                    "phone_ext": "2951"
                }, 
                "contact_backup": {
                    "email": "m.v.ramshorst@nki.nl", 
                    "last_name": "Mette S van Ramshorst, M", 
                    "phone": "+3120512", 
                    "phone_ext": "6196"
                }, 
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "zip": "1066 CX"
                    }, 
                    "name": "Antoni van Leeuwenhoek"
                }, 
                "investigator": {
                    "last_name": "Gabe S Sonke, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "J M Meerum Terwogt, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "zip": "1090 HM"
                    }, 
                    "name": "OLVG"
                }, 
                "investigator": {
                    "last_name": "J M Meerum Terwogt, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "zip": "1081 HV"
                    }, 
                    "name": "AZVU"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "email": "agoosens@rkz.nl", 
                    "last_name": "A N Goosens, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Beverwijk", 
                        "country": "Netherlands", 
                        "zip": "1940 EB"
                    }, 
                    "name": "Rode Kruis Ziekenhuis"
                }, 
                "investigator": {
                    "last_name": "A N Goosens, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "JHeijns@amphia.nl", 
                    "last_name": "J B Heijns, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Breda", 
                        "country": "Netherlands", 
                        "zip": "4819 EV"
                    }, 
                    "name": "Amphia ziekenhuis"
                }, 
                "investigator": {
                    "last_name": "J B Heijns, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "V O Dezentje, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Delft", 
                        "country": "Netherlands", 
                        "zip": "2625 AD"
                    }, 
                    "name": "Reinier de Graaf Groep"
                }, 
                "investigator": {
                    "last_name": "V O Dezentje, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "T. Smilde, MD, PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Den Bosch", 
                        "country": "Netherlands"
                    }, 
                    "name": "Jeroen Bosch Hospital"
                }, 
                "investigator": {
                    "last_name": "T. Smilde, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "den Haag", 
                        "country": "Netherlands", 
                        "zip": "2597 AX"
                    }, 
                    "name": "Bronovo Ziekenhuis"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "email": "j.portielje@hagaziekenhuis.nl", 
                    "last_name": "J E Portielje, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Den Haag", 
                        "country": "Netherlands", 
                        "zip": "2545 CH"
                    }, 
                    "name": "Haga"
                }, 
                "investigator": {
                    "last_name": "J E Portielje, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "imholza@dz.nl", 
                    "last_name": "A L Imholz, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Deventer", 
                        "country": "Netherlands", 
                        "zip": "7416 SE"
                    }, 
                    "name": "Deventer ziekenhuis"
                }, 
                "investigator": {
                    "last_name": "A L Imholz, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "haringhuizena@zgv.nl", 
                    "last_name": "A W Haringhuizen, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Ede", 
                        "country": "Netherlands", 
                        "zip": "6716 RP"
                    }, 
                    "name": "Ziekenhuis Gelderse Vallei"
                }, 
                "investigator": {
                    "last_name": "A W Haringhuizen, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "L W Tick, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Eindhoven", 
                        "country": "Netherlands", 
                        "zip": "5631 BM"
                    }, 
                    "name": "Maxima Medisch Centrum"
                }, 
                "investigator": {
                    "last_name": "L W Tick, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Eindhoven", 
                        "country": "Netherlands", 
                        "zip": "5602 ZA"
                    }, 
                    "name": "Catharina Ziekenhuis"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "email": "a.smals@st-anna.nl", 
                    "last_name": "A Smals, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Geldrop", 
                        "country": "Netherlands", 
                        "zip": "5664 EH"
                    }, 
                    "name": "St Anna Geldrop"
                }, 
                "investigator": {
                    "last_name": "A Smals, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Geleen", 
                        "country": "Netherlands", 
                        "zip": "6162 BG"
                    }, 
                    "name": "Orbis Medisch Centrum"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "email": "bea.tanis@ghz.nl", 
                    "last_name": "B C Tanis, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Gouda", 
                        "country": "Netherlands", 
                        "zip": "2803 HH"
                    }, 
                    "name": "Groene Hart"
                }, 
                "investigator": {
                    "last_name": "B C Tanis, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Haarlem", 
                        "country": "Netherlands", 
                        "zip": "2035 RC"
                    }, 
                    "name": "Kennemer Gasthuis"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "last_name": "F van de Berkmortel, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Heerlen", 
                        "country": "Netherlands", 
                        "zip": "6401 CX"
                    }, 
                    "name": "Atrium Medisch Centrum Parkstad"
                }, 
                "investigator": {
                    "last_name": "F van de Berkmortel, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "bdevalk@spaarneziekenhuis.nl", 
                    "last_name": "B de Valk, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Hoofddorp", 
                        "country": "Netherlands", 
                        "zip": "2134 TM"
                    }, 
                    "name": "Spaarne ziekenhuis"
                }, 
                "investigator": {
                    "last_name": "B de Valk, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "s.m.vandenheiligenberg@westfriesgasthuis.nl", 
                    "last_name": "S M van den Heiligenberg, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Hoorn", 
                        "country": "Netherlands", 
                        "zip": "1624 NP"
                    }, 
                    "name": "Westfries Gasthuis"
                }, 
                "investigator": {
                    "last_name": "S M van den Heiligenberg, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "graafhi@znb.nl", 
                    "last_name": "H de Graaf, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Leeuwarden", 
                        "country": "Netherlands", 
                        "zip": "8934 AD"
                    }, 
                    "name": "MCL"
                }, 
                "investigator": {
                    "last_name": "H de Graaf, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leiden", 
                        "country": "Netherlands", 
                        "zip": "2300 RC"
                    }, 
                    "name": "LUMC"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Meppel", 
                        "country": "Netherlands", 
                        "zip": "7943 KA"
                    }, 
                    "name": "Diaconessenhuis Meppel"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "last_name": "C.M.P.W. Mandigers, MD, PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Nijmegen", 
                        "country": "Netherlands"
                    }, 
                    "name": "Canisius-Wilhelmina Hospital"
                }, 
                "investigator": {
                    "last_name": "C.M.P.W. Mandigers, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "brakenhoff@wlz.nl", 
                    "last_name": "Brakenhoff, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Purmerend", 
                        "country": "Netherlands", 
                        "zip": "1441 RN"
                    }, 
                    "name": "Waterlandziekenhuis"
                }, 
                "investigator": {
                    "last_name": "Brakenhoff, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Q C van Rossum-Schornagel, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Schiedam", 
                        "country": "Netherlands", 
                        "zip": "3100 AE"
                    }, 
                    "name": "Vlietland Ziekenhuis"
                }, 
                "investigator": {
                    "last_name": "Q C van Rossum-Schornagel, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "jmgriel@elisabeth.nl", 
                    "last_name": "J M van Riel, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Tilburg", 
                        "country": "Netherlands", 
                        "zip": "5022 GC"
                    }, 
                    "name": "St. Elisabeth"
                }, 
                "investigator": {
                    "last_name": "J M van Riel, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "dtbokkel@diakhuis.nl", 
                    "last_name": "D ten Bokkel Huinink, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Utrecht", 
                        "country": "Netherlands", 
                        "zip": "3582 KE"
                    }, 
                    "name": "Diaconessenhuis Utrecht"
                }, 
                "investigator": {
                    "last_name": "D ten Bokkel Huinink, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Venlo", 
                        "country": "Netherlands"
                    }, 
                    "name": "VieCuri Medisch Centrum voor Noord-Limburg"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "email": "bakker.sd@zaansmc.nl", 
                    "last_name": "S Bakker, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Zaandam", 
                        "country": "Netherlands", 
                        "zip": "1502 DV"
                    }, 
                    "name": "Zaans Medisch Centrum"
                }, 
                "investigator": {
                    "last_name": "S Bakker, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "a.h.honkoop@isala.nl", 
                    "last_name": "A H. Honkoop, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Zwolle", 
                        "country": "Netherlands", 
                        "zip": "8025 AB"
                    }, 
                    "name": "Isala Klinieken"
                }, 
                "investigator": {
                    "last_name": "A H Honkoop, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Netherlands"
        }, 
        "number_of_arms": "2", 
        "official_title": "Optimizing Neoadjuvant Systemic Treatment for HER2 Positive Breast Cancer - the TRAIN-2 Study", 
        "overall_contact": {
            "email": "m.v.ramshorst@nki.nl", 
            "last_name": "Mette S van Ramshorst, MD", 
            "phone": "+3120512", 
            "phone_ext": "6169"
        }, 
        "overall_contact_backup": {
            "email": "g.sonke@nki.nl", 
            "last_name": "Gabe S Sonke, MD", 
            "phone": "+3120512", 
            "phone_ext": "2951"
        }, 
        "overall_official": {
            "affiliation": "Antoni van Leeuwenhoek, Amsterdam", 
            "last_name": "Gabe S Sonke, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To compare the efficacy of six cycles neoadjuvant PTC plus pertuzumab preceded by either three cycles of FEC-T plus pertuzumab or three cycles of PTC plus pertuzumab in HER2 positive breast cancer", 
            "measure": "Number of patients with pathological complete response", 
            "safety_issue": "No", 
            "time_frame": "at week 30"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01996267"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "to describe the safety of the various regimens toxicity is compared between the two arms", 
                "measure": "Number of patients with grade >2 adverse events as a measure of safety and tolerability", 
                "safety_issue": "Yes", 
                "time_frame": "up to week 35"
            }, 
            {
                "description": "To identify prognostic and predictive biomarkers for pCR after neoadjuvant treatment", 
                "measure": "identify prognostic and predictive biomarkers for pCR", 
                "safety_issue": "No", 
                "time_frame": "within one year after end of treatment"
            }
        ], 
        "source": "The Netherlands Cancer Institute", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Roche Pharma AG", 
                    "agency_class": "Industry"
                }, 
                {
                    "agency": "Borstkanker Onderzoek Groep", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "The Netherlands Cancer Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}